$187,000 to $6.30: Drug subsidy gives hope to cancer sufferers

By Adam Gartrell
Updated June 28 2018 - 1:23pm, first published October 9 2017 - 12:00am
Jim Coomes was given 18 months to live when he was diagnosed with CLL four years ago. He has taken Imbruvica for three years after being given compassion access. Photo: Darrian Traynor.
Jim Coomes was given 18 months to live when he was diagnosed with CLL four years ago. He has taken Imbruvica for three years after being given compassion access. Photo: Darrian Traynor.

A BREAKTHROUGH leukaemia and lymphoma drug that normally costs $187,000 per treatment will become easily affordable under a new $460 million Turnbull government subsidy.

Create a free account to read this article

$0/

(min cost $0)

or signup to continue reading

Get the latest Senior news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.